An efficient taurine-catalyzed green multicomponent approach has been described for the first time to synthesize densely substituted therapeutic core dihydropyrano[2,3-]pyrazoles. Applications of the developed synthetic strategies and technologies revealed the synthesis of a series of newly designed 1,4-dihydropyrano[2,3-]pyrazoles containing isonicotinamide, spirooxindole, and indole moieties. Detailed analysis of the synthesized analogues revealed their potential to bind wild-type and antibiotic-resistant variants of dihydrofolate reductase, a principal drug target enzyme for emerging antibiotic-resistant pathogenic strains. Hence, the synthesized dihydropyrano[2,3-]pyrazole derivatives presented herein hold immense promise to develop future antistaphylococcal therapeutic agents.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600639 | PMC |
http://dx.doi.org/10.1021/acsomega.1c04773 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!